Literature DB >> 12435231

Severe but reversible cholestatic liver injury after pioglitazone therapy.

Amar G Pinto, Oscar W Cummings, Naga Chalasani.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2002        PMID： 12435231     DOI： 10.7326/0003-4819-137-10-200211190-00023

Source DB:  PubMed          Journal:  Ann Intern Med        ISSN： 0003-4819            Impact factor:   25.391


× No keyword cloud information.
  8 in total

Review 1.  Important elements for the diagnosis of drug-induced liver injury.

Authors:  Vijay K Agarwal; John G McHutchison; Jay H Hoofnagle
Journal:  Clin Gastroenterol Hepatol       Date:  2010-02-17       Impact factor: 11.382

2.  Prediction of drug-induced liver injury using keratinocytes.

Authors:  Rika Hirashima; Tomoo Itoh; Robert H Tukey; Ryoichi Fujiwara
Journal:  J Appl Toxicol       Date:  2017-01-31       Impact factor: 3.446

Review 3.  Practical guidelines for diagnosis and early management of drug-induced liver injury.

Authors:  Kazuto Tajiri; Yukihiro Shimizu
Journal:  World J Gastroenterol       Date:  2008-11-28       Impact factor: 5.742

4.  Mitochondrial dysfunction and delayed hepatotoxicity: another lesson from troglitazone.

Authors:  N L Julie; I M Julie; A I Kende; G L Wilson
Journal:  Diabetologia       Date:  2008-08-23       Impact factor: 10.122

5.  Monitoring the safety of pioglitazone : results of a prescription-event monitoring study of 12,772 patients in England.

Authors:  Rachna Kasliwal; Lynda V Wilton; Saad A W Shakir
Journal:  Drug Saf       Date:  2008       Impact factor: 5.606

Review 6.  Pioglitazone for type 2 diabetes mellitus.

Authors:  B Richter; E Bandeira-Echtler; K Bergerhoff; C Clar; S H Ebrahim
Journal:  Cochrane Database Syst Rev       Date:  2006-10-18

Review 7.  Evidence-based selection of training compounds for use in the mechanism-based integrated prediction of drug-induced liver injury in man.

Authors:  Sanja Dragovic; Nico P E Vermeulen; Helga H Gerets; Philip G Hewitt; Magnus Ingelman-Sundberg; B Kevin Park; Satu Juhila; Jan Snoeys; Richard J Weaver
Journal:  Arch Toxicol       Date:  2016-09-22       Impact factor: 5.153

8.  Pioglitazone-Mediated Peroxisome Proliferator-Activated Receptor γ Activation Aggravates Murine Immune-Mediated Hepatitis.

Authors:  Rike Schulte; Dirk Wohlleber; Ludmilla Unrau; Bernd Geers; Christina Metzger; Annette Erhardt; Gisa Tiegs; Nico van Rooijen; Lukas C Heukamp; Luisa Klotz; Percy A Knolle; Linda Diehl
Journal:  Int J Mol Sci       Date:  2020-04-05       Impact factor: 5.923
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.